About LyoPep
LyoPep connects a broad peptide catalog, batch documentation requests and B2B project coordination in one workflow. Public claims remain limited to evidence that can be produced for buyer review.
Operating principle
Product discovery, batch documentation, technical questions, OEM briefs and follow-up live in one conversion path. That reduces the gap between “I found a molecule” and “I sent a usable RFQ.”
Founder's note
Buyers should not have to choose between evidence they can verify and pricing their research can sustain. Yet the peptide supply market is fragmented: specifications are often incomplete, batch evidence can be difficult to compare, and a low price can leave important questions unanswered.
We built LyoPep to make qualified Chinese supply easier to evaluate. Our goal is to connect buyers with competitively priced research-use peptides while making specifications, batch documentation, manufacturing scope and commercial terms visible before commitment. We do not ask buyers to trust a slogan; we want each decision to be supported by evidence that can be reviewed.
After reviewing the documentation made available to us, assessing the presented facilities and technical scope, and evaluating product and testing information, we selected Wuhan Joylem Health Tech Limited as the manufacturer represented through LyoPep. We believe the R&D, production and analytical capabilities presented during that process provide a strong basis for cooperation. Buyers should still confirm the current facility scope, methods and released-batch evidence for each project.
Affordable should not mean uncheckable.
Facility and production
The sequence follows the evidence a B2B buyer reviews: people, equipment, line controls, packaging and dispatch context.
The cleanroom team image places personnel, equipment and operating records in the same working context.
How to read this evidence
Photographs and tours help procurement teams understand the presented environment. Current legal-entity, facility, certificate, product-scope and released-batch documents must still be checked for the order under review.
The production-room view provides spatial context for equipment layout and controlled operations.
Factory and warehouse · 00:26
This edited sequence focuses on installed production equipment, packaging-area transitions and downstream warehouse staging. Laboratory footage is presented separately in the Laboratory section below.
Use the walkthrough for orientation only; during supplier qualification, confirm the current site, process scope, storage conditions and order-specific records.
Operators monitor packed units, coding and presentation while the line is running.
Manual review complements line controls where presentation, count and handoff need confirmation.
Warehouse organization supports batch-aware storage, picking and dispatch review.
Production line · 01:04
This closer view brings vial movement, line pace and equipment interfaces into focus. The final project brief still defines component checks, fill, label version, batch coding and release documentation.
Operators review settings and process status at enclosed equipment before the next handoff.
Line configuration and in-process checks must match the approved fill and component specification.
The enclosed workstation shows how a product-contact step can be separated from the surrounding work area.
Laboratory
A familiar instrument is not enough on its own. Buyers should confirm method suitability, sample preparation, system suitability and the laboratory's scope for the supplied form.
The wide view shows how analysts, extraction points and multiple instrument platforms share the laboratory floor.
Qualification questions
Preparation and system suitability are part of whether a result can be interpreted.
Data review should remain connected to the method, sample and batch being assessed.
LyoPep's founder toured the factory and laboratory and joined the laboratory team for a group photo.
Laboratory walkthrough · 00:18
The short tour shows analysts working across the instrument area. For a purchasing decision, request the method and batch-specific evidence that answers the exact identity, purity or content question.
Claims point to a page, method, lot or source that a buyer can inspect.
One test never stands in for a complete risk assessment.
Representative media and public claims remain distinguishable from transaction-specific evidence until the supporting records are reviewed.
Site-wide contact paths keep WhatsApp and email available, with quote and COA requests at relevant decision points.